Micronuclei and p53 accumulation in preneoplastic and malignant lesions of the head and neck

被引:21
|
作者
Delfino, V
Casartelli, G
Garzoglio, B
Scala, M
Mereu, P
Bonatti, S
Margarino, G
Abbondandolo, A
机构
[1] Natl Inst Canc Res, I-16132 Genoa, Italy
[2] CNR, Inst Mutagenesis & Differentiat, Pisa, Italy
[3] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy
关键词
D O I
10.1093/mutage/17.1.73
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
No single biomarker can predict the risk for malignant trasformation of precancerous lesions of the head and neck. Micronucleus frequency, nuclear p53 accumulation and mitotic index were determined in proliferating basal cells using paraffin-embedded specimens from normal, dysplastic and malignant tissues. p53 accumulation was detected by immunohistochemistry using pAb 1081 and pAb 240 antibodies. Micronuclei were scored in the same cell population and classified for the presence/absence of p53 accumulation in the main nucleus. Fifty-three carcinomas and 15 precancerous lesions were studied. Both micronuclei and p53 accumulation were found in precancerous lesions, suggesting that they are early events in head and neck squamous cell carcinoma progression. The two biomarkers were not related to each other: indeed, micronucleus frequency was higher in p53-negative than in p53-positive cells. Three patients with precancerous lesions later developed carcinomas; all three cases showed high frequencies of both micronuclei and cells accumulating p53 protein.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [31] P53 TOPOGRAPHIC GENOTYPING OF MULTIFOCAL PRIMARY HEAD AND NECK
    ROSENDALE, B
    RIBEIRO, U
    SAFATLERIBEIRO, AV
    POSNER, MC
    BAKKER, A
    SWALSKY, PA
    REYNOLDS, JC
    FINKELSTEIN, SD
    LABORATORY INVESTIGATION, 1995, 72 (01) : A104 - A104
  • [32] P53, A CELL PROTEIN IN HEAD-NECK TUMORS
    ISSING, WJ
    HNO, 1994, 42 (05) : 249 - 250
  • [34] p53 phase II trial for head and neck cancer
    不详
    DRUG NEWS & PERSPECTIVES, 1997, 10 (08) : 506 - 506
  • [35] The Tumor Suppressor p53 in Mucosal Melanoma of the Head and Neck
    Fritsche, Marie Kristin
    Knopf, Andreas
    GENES, 2017, 8 (12)
  • [36] P53 overexpression in head and neck carcinoma and radiotherapy results
    Awwad, S
    Jaros, E
    Soames, J
    Lunec, J
    BRITISH JOURNAL OF CANCER, 1996, 74 : PO36 - PO36
  • [37] Multidisciplinary treatment with P53 biomarker for head and neck cancer
    Fukazawa, H
    Takagi, R
    Ohashi, Y
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 521 - 525
  • [39] p53 protein expression in benign and malignant breast lesions
    Ioakim-Liossi, A
    Markopoulos, C
    Karakitsos, P
    Safioleas, M
    Gogas, T
    Vaiopoulos, G
    ACTA CYTOLOGICA, 1998, 42 (04) : 918 - 922
  • [40] Expression of p185 and p53 in benign and malignant colorectal lesions
    Porcelli, B
    Frosi, B
    Terzuoli, L
    Arezzini, L
    Marinello, E
    Vernillo, R
    De Martino, A
    Vatti, R
    Minacci, C
    HISTOCHEMICAL JOURNAL, 2001, 33 (01): : 51 - 57